210346-49-9

Basic information

• Product Name: 8-AMINO-1-TETRALONE
• Synonyms: 8-AMINO-1-TETRALONE;8-AMINO-3,4-DIHYDRONAPHTHALEN-1(2H)-ONE;8-Amino-3,4-dihydro-2H-naphthalen-1-one;8-Amino-3,4-dihydro-1(2H)-naphthalenone;8-AMINO-1-TETRALONE HCL
• CAS NO: 210346-49-9
• Molecular Formula: C₁₀H₁₁NO
• Molecular Weight: 161.2
• Mol File: 210346-49-9.mol

Chemical Properties

• Melting Point: 84-85℃
• Boiling Point: 342.4°Cat760mmHg
• Flash Point: 160.9°C
• Appearance: /
• Density: 1.193g/cm³
• Vapor Pressure: 7.53E-05mmHg at 25°C
• Refractive Index: 1.619
• Storage Temp.: 2-8°C(protect from light)
• PKA: 2.26±0.20(Predicted)
• CAS DataBase Reference: 8-AMINO-1-TETRALONE(CAS DataBase Reference)
• NIST Chemistry Reference: 8-AMINO-1-TETRALONE(210346-49-9)
• EPA Substance Registry System: 8-AMINO-1-TETRALONE(210346-49-9)

Safety Data

• Hazardous Substances Data: 210346-49-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
8-Amino-1-tetralone is used as a key intermediate in the synthesis of various pharmaceuticals for its cytotoxic properties against cancer cells. It plays a crucial role in the development of anticancer drugs, offering potential therapeutic benefits in cancer treatment.
Used in Chemical Industry:
In the chemical industry, 8-Amino-1-tetralone is utilized in the production of dyes and pigments. Its ability to form complex colorants makes it a valuable component in creating a wide range of color products for different applications.
Overall, 8-Amino-1-tetralone's diverse applications in pharmaceuticals, dyes, and pigments highlight its significance in both industrial and medicinal fields, driven by its unique chemical characteristics.

InChI:InChI=1/C10H11NO/c11-8-5-1-3-7-4-2-6-9(12)10(7)8/h1,3,5H,2,4,6,11H2

Upstream product

• 2217-41-6 1-amino-5,6,7,8-tetrahydronaphthalene 
• 6272-18-0 N-(5,6,7,8-tetrahydronaphthalen-1-yl)acetamide 
• 887945-40-6 (8-oxo-5,6,7,8-tetrahydro-naphthalen-1-yl)-carbamic acid tert-butyl ester 
• 110139-15-6 N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide 
• 58161-31-2 8-nitro-3,4-dihydro-1(2H)naphthalenone 

Downstream Products

• 628731-58-8 8-fluoro-3,4-dihydronaphthalene-1(2H)-one 
• 68449-32-1 8-chloro-1,2,3,4-tetrahydro-naphthalen-1-one 
• 651735-60-3 8-bromo-3,4-dihydronaphthalene-1(2H)-one 
• 651735-61-4 8-iodo-3,4-dihydronaphthalen-1(2H)-one 
• 887945-65-5 (8-oxo-5,6,7,8-tetrahydro-naphthalen-1-ylamino)-phenyl-acetic acid methyl ester 
• 65832-15-7 1,3,4,5-Tetrahydrobenzindazol 
• 1415588-51-0 (4S,5R)-3-(furan-2-carbonyl)-5-methyl-N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)oxazolidine-4-carboxamide 
• 1415588-50-9 (S)-3-(furan-2-carbonyl)-N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)oxazolidine-4-carboxamide 

Relevant articles and documents

INHINITORS OF GLI1 AS THERAPEUTIC AGENTS

This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to glioma- associated oncogene (Gli) expression. More particularly, this disclosure relate

5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE

Provided in some embodiments are compounds of Formula A, as defined herein, that modulate the activity of 5-HT2C receptor. Also provided in some embodiments are methods, such as, for weight management, inducing satiety, and decreasing food intake, and for

NAPTHOQUINONES, PRO-DRUGS, AND METHODS OF USE THEREOF

Provided herein are naphthoquinones compounds such as those with a hydrogen bond donating group of the formula (I): wherein: R1, R2, R3, R4, R5, and n are as defined herein. Also provided herein are pharmaceutical composition of the present compounds and methods of treatment using the compounds including their use in the treatment of cancer.

CARBAMATE DERIVATIVE COMPOUNDS, PROCESSES FOR PREPARING THEM AND THEIR USES

The present invention relates to a pharmaceutical composition for treating or preventing CNS disorders containing a carbamate derivative compound and/or pharmaceutically acceptable salt thereof as an active ingredient. Furthermore, the present invention relates to a method for treatment or prevention CNS disorders comprising administering a carbamate derivative compound in a pharmaceutically effective amount to a subject in need of treatment or prevention of CNS disorders.

Development of a new family of chiral auxiliaries

A new family of chiral auxiliaries designed on a conformationally restricted version of (-)-8-phenylmenthol has been developed. Both enantiomers are available from an inexpensive synthesis conducted on multigram scale. A first application has showed compa

Photoassisted synthesis of enantiopure alkaloid mimics possessing unprecedented polyheterocyclic cores

Enantiopure alkaloid mimics are synthesized via high yielding intramolecular cycloadditions of photogenerated azaxylylenes tethered to pyrroles, with further growth of molecular complexity via post-photochemical transformations of primary photoproducts. This expeditious access to structurally unprecedented polyheterocyclic cores is being developed in the context of diversity-oriented synthesis, as the modular design allows for rapid "pre-assembly" of diverse photoprecursors from simple building blocks/diversity inputs.

Rapid photoassisted access to N,O,S-polyheterocycles with benzoazocine and hydroquinoline cores: Intramolecular cycloadditions of photogenerated azaxylylenes

Ring the changes: A new photoassisted approach to give conformationally constrained N,O,S-polyheterocyclic scaffolds of unprecedented topologies was achieved by intramolecular [4+4] and [4+2] cycloadditions of photogenerated o-azaxylylenes (23 examples; see scheme). The precursors can be readily assembled by simple and high-yielding reactions, thus making this a powerful synthetic method amenable to high-throughput diversity-oriented synthesis.

Substituted Nitrogen Heterocycles and Synthesis and Uses Thereof

The invention relates to a nitrogen heterocycle compound of formula 1: Also disclosed are a method of synthesizing the compound and use of the compound for treating various diseases and conditions.

Synthesis and structure-activity relationships of N-substituted spiropiperidines as nociceptin receptor ligands

A series of N-substituted analogs based upon the spiropiperidine core of 1 was synthesized and exhibited high binding affinity to the nociceptin (NOP) receptor. The selectivities against other known opioid receptors were determined.

N-PHENYL-1,1,1-TRIFLUOROMETHANESULFONAMIDE HYDRAZONE DERIVATIVE COMPOUNDS AND THEIR USAGE IN CONTROLLING PARASITES

Novel N-phenyl-1,1,1-trifluoromethanesulfonamide compounds useful for controlling endo and/or ectoparasites in the environment are provided, together with methods of making the same, and methods of using the inventive compounds to treat parasite infestations in vivo and ex vivo.